Skip to main content
Retour
Watch Compare

IMMUNIC, INC.

Qualité des données : 83%
IMUX
Nasdaq Manufacturing Chemicals
1,29 €
▲ 0,10 € (8,40%)
Cap. Boursière: 168,30 M
Prix
1,29 €
Cap. Boursière
168,30 M
Fourchette du Jour
1,18 € — 1,29 €
Fourchette 52 Semaines
0,51 € — 1,51 €
Volume
1 195 171
Ouverture 1,18 €
Moyenne 50J / 200J
0,98 €
31,58% above
Moyenne 50J / 200J
0,84 €
54,36% above

Quick Summary

Points Clés

Negative free cash flow of -85,97 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-437,61%
En dessous de la moyenne du secteur (-53,41%)
ROIC-364,54%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,31
Interest CoverageN/A

Valorisation

PE (TTM)
-1,73
En dessous de la moyenne du secteur (-1,48)
P/B Ratio16,03
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -1,7 -1,5
P/B 16,0 1,6
ROE % -437,6 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

BRSIX BRSIX
0,13% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -97,17 M
ROE -437,61% ROA -190,29%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -85,97 M
ROIC -364,54% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,31
Interest Coverage N/A Asset Turnover N/A
Working Capital 9,19 M Tangible Book Value 10,50 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,73 Forward P/E N/A
P/B Ratio 16,03 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -51,08%
Market Cap 168,30 M Enterprise Value 133,17 M
Per Share
EPS (Diluted TTM) -0,62 Revenue / Share N/A
FCF / Share -0,66 OCF / Share -0,66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88,47%
SBC-Adj. FCF -95,43 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -97,17 M -100,51 M -93,61 M -120,41 M -92,95 M
EPS (Diluted) -0,62 -1,00 -2,11 -3,78 -3,93
Gross Profit — — — — —
Operating Income -103,23 M -98,05 M -99,22 M -119,49 M -91,67 M
EBITDA — — — — —
R&D Expenses 81,98 M 80,05 M 83,22 M 71,26 M 61,12 M
SG&A Expenses — — — — —
D&A 168 000,0 134 000,0 111 000,0 77 000,0 85 000,0
Interest Expense — — — — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 24,05 M 40,87 M 54,30 M 127,75 M 139,10 M
Total Liabilities 30,73 M 22,44 M 25,37 M 14,07 M 11,99 M
Shareholders' Equity -6,67 M 18,43 M 28,93 M 113,68 M 127,12 M
Total Debt — — — — —
Cash & Equivalents 15,48 M 35,67 M 46,67 M 106,75 M 86,86 M
Current Assets 22,87 M 39,33 M 52,53 M 125,86 M 104,99 M
Current Liabilities 30,62 M 22,18 M 24,73 M 13,08 M 11,40 M